Fact CheckerSign in

NCT07159360Not yet recruiting

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Source: ClinicalTrials.gov · Last updated 8 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Neurodevelopmental disorders often result in abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as the inability to stand and walk. CLINICAL EXPLORER is a clinical-use robotic device for gait training, representing the evolution of the ATLAS 2030 exoskeleton and the EXPLORER device for home use. The aim of this study is to evaluate the safety and usability of CLINICAL EXPLORER .

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
23 May 2025
Start date
15 Sept 2025
Primary completion date
1 Oct 2025
Lead sponsor
MarsiBionics
NCT number
NCT07159360

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 15 Sept 2025 to the primary completion date, 1 Oct 2025
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Allergy to any of the materials of the EXPLORER CLÍNICO: cotton, nylon, polyester, PPS, PEEK, or ABS. The materials used in EXPLORER CLÍNICO that were not previously used in ATLAS 2030, a medical device certified by the AEMPS, are PPS, PEEK, and ABS.

Other illness

  • History of fracture without trauma.
  • Presence of other conditions that cause exercise intolerance (such as uncontrolled hypertension, coronary artery diseases, arrhythmia, congestive heart failure, severe pulmonary disease).
  • Behavioral disorders that interfere with proper use of the device, such as impulsivity.

Other

  • Any medical contraindication for standing or walking.
  • Presence of non-reducible contractures or heterotopic ossification above the degrees allowed by the device and/or outside the trajectory imposed by the device.
  • Spasticity (MAS) = 4 in lower limbs at the time of device use.
  • Structured hip and/or knee contracture greater than 20 degrees.
  • Inability to stand or walk with more than 5 degrees of hip abduction.
  • Inability to achieve 5 degrees of dorsal ankle flexion from the neutral position with or without orthosis.
  • Tibial leg length discrepancy that cannot be mitigated with the use of a foot wedge.
  • Skin alterations in areas of contact with the device.

Who the study is looking for

  • Age between 2 and 17 years.
  • Consent from the participant or legal guardian to participate in the study.
  • No diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria for Phase 1
  • Age between 2 and 17 years.
  • Consent from the participant or legal guardian to participate in the study.
  • Diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria Related to the EXPLORER CLINICAL Device Characteristics
  • Medical authorization to stand upright and perform weight-bearing gait training.
  • Weight less than or equal to 60 kg.
  • Hip width less than or equal to 40 cm.
  • Distance from the hip joint center to the knee joint center: 21 cm - 36 cm.
  • Distance from the knee joint center to the ankle joint center: 20 - 35 cm.
  • EU shoe size less than or equal to 40.

Age in the registry: 2 years to 17 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Asociación Pro Personas con Paralisis Cerebral (APAC-IAP)
Coordinator of this site? Confirm its status
Mexico CityMexicoUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.